Influence of increased CD4 cell counts on the genetic variability of hepatitis C virus in patients co-infected with human immunodeficiency virus I

• Published in: Journal of biomolecular techniques Vol. 17; no. 3; pp. 228 - 239
• Main Authors: Wang, Xue-Ping, Goodwin, Leslie, Kahn, Pamela, Gawel, Craig, Cunha, Cheston B, Laser, Benjamin, Sahn, Benjamin, Kaplan, Mark H
• Format: Journal Article
• Language: English
• Published: United States The Association of Biomolecular Resource Facilities 01.07.2006
• Subjects: Amino Acid Sequence; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Female; Genetic Variation; Hepacivirus - genetics; Hepacivirus - immunology; Hepatitis C - complications; Hepatitis C - genetics; Hepatitis C - immunology; HIV Infections - complications; HIV Infections - immunology; HIV-1 - immunology; Humans; Male; Middle Aged; Molecular Sequence Data; Retrospective Studies
• ISSN: 1524-0215

In order to study the effect of increased CD4 cell counts on the biology of hepatitis C virus (HCV), we analyzed the genetic variability of HCV generated over 8 y in eight human immunodeficiency virus-1 (HIV-1) and HCV co-infected patients. This was a retrospective study in which HIV patients were selected who had profound immune impairment evident over four years and were co-infected with HCV genotype 1 and who then went on highly active antiretroviral therapy (HAART). These patients achieved different degrees of immune reconstitution, measured as increased CD4 cell counts during a 4- to 8-y period, following initiation of HAART. HCV genetic variability was determined by measuring the genetic diversity (Hamming distance, HD), and complexity (number of viral variants) in plasma samples collected at yearly intervals just before and after the initiation of HAART. The parameters were assessed by molecular cloning and sequencing of a 575-bp fragment including the HCV envelope 1 and envelope 2 genes (E1/E2), containing the hypervariable region 1 (HVR1). significantly increased HVR1 genetic diversity was observed in analyzed samples where the patients' CD4 cell counts were > or =100 compared with CD4 cell counts <100. A significant increase in genetic diversity in HVR1 was detected in co-infected patients whose CD4 cell counts increased from <100 to >400 over a period of more than 4 y of HAART therapy. This was in contrast to a minimal increase in HCV genetic diversity of HVR1 occurring in patients whose CD4 cell counts failed to rise much over 200 over 7 y of follow up. Insertion and deletion of HCV genomic fragments in the E1/E2 region was documented in one patient who developed fulminant hepatitis C.